News

AddToAny

Google+ Facebook Twitter Twitter

Blood sample analysis

Nightingale Health will analyse the biomarker profiles of 500,000 blood samples from UK Biobank. 

p8-13-News-Blood-testing--Istock--520292052.jpg

Nightingale’s biomarker profiling technology will be used to analyse UK Biobank blood samples by measuring metabolic biomarkers that recent studies have found are predictive of future risk for heart disease, type 2 diabetes and many other common chronic diseases.

Until recently, technological constraints and prohibitive costs have prevented the analysis of comprehensive metabolic data from large-scale biobank collections.

nightingalehealth.com
 

Image credit | iStock

Related Articles

Blood Group Blood Bag Science Photo Library

The Lewis Blood Group System and Secretor Status

Malcolm Needs CSci FIBMS, formerly of the NHSBT, delves into the history and science of a notable blood group system.

Raised serum ferritin

Honorary senior lecturer and consultant haematologist Dr Farooq A Wandroo and his colleagues ask, what is the clinical significance of a markedly elevated serum ferritin?

Blood test for Alzheimer’s

Investigators at Brigham and Women’s Hospital in the US are working to develop a blood test that could accurately diagnose or even predict Alzheimer’s disease before symptoms appear.

Clinical chemistry classics: tumour markers

This series on tumour markers concludes with a review of pioneering work in the development, analysis and clinical application of an important serum tumour marker – prostate specific antigen.

Top